As regulators increasingly focus on individual accountability, can manufacturing leaders afford to treat data governance as a back-office function?

Will the next generation of blockbuster therapies be won by science alone or by the speed of manufacturing execution?

A wave of small interfering RNA therapeutics targeting prevalent cardiometabolic diseases is anticipated to drive active pharmaceutical ingredients demand beyond the scale that existing manufacturing models were designed to support. Meeting this demand will require coordinated advances in manufacturing technology and supply chain structure alongside substantial investment in global production capacity

In the fast-paced, competitive world of generics manufacturing, processes such as integrated dissolution-absorption testing can mean the difference between first to market and obscurity

Pharmaceutical manufacturers are rethinking operational resilience as connected systems, automation and infrastructure dependencies play a larger role in production. Continuity now depends on more than equipment performance. It also depends on how well companies coordinate technology, workforce oversight and compliance across increasingly integrated manufacturing environments

Miriam Krechlok from Mettler-Toledo Product Inspection speaks to IPT about advanced contamination detection systems and how these are utilised in pharma manufacturing to ensure seamless and good manufacturing practice-compliant products

How are life sciences organisations embracing new technologies to help develop soft skills, hopefully mitigating issues seen in the pharma manufacturing sector?

The future of aseptic pharmaceutical manufacturing is gloveless, but what might sound like a bold vision is already turning into reality today

Early-phase development has always required urgency. Today, that urgency is shaped by a more complex set of pressures than ever before. Competitive intensity, milestone-driven financing structures and expanding regulatory expectations are redefining how biotech and virtual pharma companies approach the earliest stages of development.

How is semantic layering technology addressing significant efficiency gaps, creating the infrastructure for more efficient manufacturing operations?

Process innovations provide opportunities to reduce environmental impact while improving efficiency and product quality

How is X-ray CT being used to ensure quality in tabletting?